Auntea Jenny Announces 2026 Interim Results 
Xunce 2026 Interim Results: Revenue Up 389%, Net profit of nearly 100 million yuan, Token Revenue Emerges as a New Growth Engine 
Aitenders Technologies Inc. (Formerly, eXeBlock Technology Corporation) Announces Closing of Reverse Takeover with Aitenders and Receipt of Conditional Listing Approval from the Canadian Securities Exchange 
New Manitoba Bonus Prize Clue Released for The Great Canadian Treasure Hunt 
GetHookd Releases API & MCP Server for AI-Powered Ecommerce Ad Research Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders
Scheduled to Reconvene on November 25, 2020Company Urgently Encourages Stockholders to Vote BUENA, N.J., Nov….
J. Knipper and Company, Inc. Finalizes Acquisition of Eagle Pharmacy to Expand Company’s Pharmacy Programs, Scale and Automation Capabilities
One of the Largest Suppliers of Pharmaceutical Marketing Solutions and Specialty Pharmacy Services in the…
Shattuck Labs Announces Preclinical Proof of Concept Study on Gamma Delta T Cell Engager, GADLEN™, Platform at SITC 2020
AUSTIN, TX and DURHAM, NC, Nov. 11, 2020 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck)…
Revive Therapeutics Provides Update on Oral Thin Film Product with Psilocybin
TORONTO, Nov. 11, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:…
Virtual KOL Roundtable Recap: Outlook Therapeutics and Firas Rahhal, MD, Discussed wet AMD Treatment Landscape and ONS-5010/LYTENAVA™
Dr. Rahhal, a leading retinal clinician, offered insight on wet AMD treatment and the potential…
Mersana Therapeutics Reports Preclinical Data from Immunosynthen STING-Agonist ADC Platform and Pipeline
Immunosynthen ADCs activate the STING pathway in both tumor-resident immune cells and in the tumor…
Sorrento Announces IND Filing for COVI-DROPS, an Intranasal Formulation of a High Potency Neutralizing Antibody Against SARS-CoV-2
IND filing today for STI-2099 (COVI-DROPS™) for a phase 1 safety and pharmacokinetic study in…
SOTIO Presents Interim Data from its Phase 1/1b Study of SO-C101 in Patients with Advanced Solid Tumors at SITC 2020
Late breaking poster demonstrates SO-C101 was well tolerated to date with no dose-limiting toxicities Confirmed…
Bellerophon to Present at the H.C. Wainwright 6th Annual Israel Conference
WARREN, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or…
BioDelivery Sciences to Present Virtually and Host 1×1 Investor Meetings at the Annual Southwest IDEAS Investor Conference on November 18
RALEIGH, N.C., Nov. 11, 2020 (GLOBE NEWSWIRE) — BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a…
Better Choice Company to Host Third Quarter 2020 Financial Results Call on November 18 at 8:30 a.m. ET
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) — Better Choice Company (OTCQB: BTTR) (“Better Choice”),…
New Therapeutic Protocols Targeting Debilitating Disorders on the Horizon
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) — via InvestorWire — Cybin Inc. (NEO: CYBN)…
Enlivex to Present Schedule for Sepsis, COVID-19 and Solid Cancer Programs at H.C. Wainwright’s 6th Annual Israel Conference
Nes Ziona, Israel, Nov. 11, 2020 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the…
Neoleukin Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
SEATTLE, Nov. 11, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
Cue Biopharma to Present at Upcoming Investor Conferences in November 2020
CAMBRIDGE, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage…
Jounce Therapeutics Presents Preclinical Data from JTX-8064 Program at the Society for Immunotherapy of Cancer’s (SITC) 35th Annual Meeting
–Preclinical data highlight Jounce’s approach to identify potential predictive and pharmacodynamic biomarkers to identify patients…
Avadel Pharmaceuticals to Present at Upcoming November 2020 Investor Conferences
DUBLIN, Ireland, Nov. 11, 2020 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company…
scPharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference
BURLINGTON, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company…
Receptor Life Sciences Names Gregory Mayes to Board of Directors
SEATTLE, Nov. 11, 2020 (GLOBE NEWSWIRE) — Receptor Life Sciences (Receptor) today announced the appointment…
CymaBay Therapeutics to Present at Upcoming Investor Conferences
NEWARK, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage…